Triggered azobenzene-based prodrugs and drug delivery systems

J Control Release. 2022 May:345:475-493. doi: 10.1016/j.jconrel.2022.03.041. Epub 2022 Mar 23.

Abstract

Azobenzene-based molecules show unique trans-cis isomerization upon ultraviolet light irradiation, which induce the change of polarity, crystallinity, stability, and binding affinity with pharmacological target. Moreover, azobenzene is the substrate of azoreductase that is often overexpressed in many pathological sites, e.g. hypoxic solid tumor. Therefore, azobenzene can be a multifunctional molecule in material science, pharmaceutical science and biomedicine because of its sensitivity to light, hypoxia and certain enzymes, hence showing potential application in site-specific smart therapy. Herein we focus on the employment of azobenzene and its derivatives for engineering triggered prodrugs and drug delivery systems, and provide an overview of photoswitchable azo-based prodrugs, the associated problems regarding the reversible isomerization and tissue penetration of ultraviolet (UV) light, as well as the potential solutions. We also present the advance of azo-bearing delivery vehicles wherein azobenzene acts as the linker, capping agent, and building block, and discuss the corresponding mechanisms for controlled cargo release, endocytosis enhancement and sensitization of free radical cancer therapy.

Keywords: Azobenzene; Drug delivery; Isomerization; Prodrug; Stimuli-responsive.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Azo Compounds / chemistry
  • Drug Delivery Systems
  • Prodrugs* / chemistry
  • Ultraviolet Rays

Substances

  • Azo Compounds
  • Prodrugs
  • azobenzene